Trace Neuroscience

Trace Neuroscience is a biotech company in South San Francisco, United States, founded in 2024. It has raised $101.0M across 1 round, most recently a $101.0M Series A in November 2024.

Breakthrough Science for People with Neurodegenerative Diseases

Founded
2024
Business Model
B2B
Total Funding
$101.0M
Last Round
$101.0M Series ANov 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

Trace Neuroscience is a biopharmaceutical company developing genomic medicines that restore UNC13A function for people living with ALS. Founder research showed that people with ALS have insufficient UNC13A protein, disrupting communication between nerves and muscles. The company lead program is an antisense oligonucleotide designed to correct UNC13A splicing and expand genomic medicine from a small genetically defined subset to the large majority of ALS cases involving TDP-43 mislocalization. Trace also sees potential for UNC13A restoration in other neurodegenerative diseases, including frontotemporal dementia and Alzheimer disease.

Summary

It has raised $101.0M in total across 1 round, most recently a $101.0M Series A round in Nov 2024. Investors include Third Rock Ventures, Atlas Venture and GV.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ANov 2024
$101.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trace Neuroscience on Indexed.vc
<a href="https://indexed.vc/companies/trace-neuroscience"><img src="https://indexed.vc/api/badge/company/trace-neuroscience" alt="Trace Neuroscience on Indexed.vc" width="260" height="76" /></a>